South Africa
Tuberculosis profile
| High TB burden | High HIV burden | High MDR-TB burden |
Population  2012 52 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 31 (3.7–86) 59 (7–164)
Mortality (HIV+TB only) 88 (75–100) 168 (144–192)
Prevalence  (includes HIV+TB) 450 (160–880) 857 (305–1 685)
Incidence  (includes HIV+TB) 530 (430–630) 1 003 (827–1 194)
Incidence (HIV+TB only) 330 (270–390) 631 (521–752)
Case detection, all forms (%) 62 (52–75)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 119 898 (40) Relapse 26 668 (51)
Smear-negative 63 210 (21) Treatment after failure 3 123 (6)
Smear-unknown / not done 71 421 (24) Treatment after default 7 788 (15)
Extrapulmonary 42 467 (14) Other 15 007 (29)
Other 0 (0)      
Total new 296 996   Total retreatment 52 586  
           
Other (history unknown) 0        
Total new and relapse 323 664   Total cases notified 349 582  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 1.3 1.1 1.0
Age < 15 2 677 33 601 2 327
Laboratories 2012
Smear (per 100 000 population) 0.4
Culture (per 5 million population) 1.4
Drug susceptibility testing (per 5 million population) 1.4
Is second-line drug susceptibility testing available? Yes, in country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 79   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 76  
Retreatment 66  
TB/HIV 2012 Number (%)
TB patients with known HIV status 294 196 (84)
HIV-positive TB patients 190 093 (65)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 140 868 (74)
HIV-positive TB patients on antiretroviral therapy (ART) 101 937 (54)
HIV-positive people screened for TB 949 800  
HIV-positive people provided with IPT 369 747  
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 1.8 (1.4–2.3) 6.7 (5.4–8.2)
MDR-TB cases among notified pulmonary
TB cases
4 600 (3 700–5 800) 3 500 (2 800–4 300)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB     37 310
Laboratory-confirmed MDR-TB cases     15 419
Patients started on MDR-TB treatment     6 494
Financing TB control 2013
National TB programme budget (US$ millions) 475
% Funded domestically 97%
% Funded internationally 3%
% Unfunded <1%
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-23 Data: www.who.int/tb/data